Other Publications
 

Document Type

Article

Publication Date

2016

Abstract

New gene-editing technologies, like CRISPR, promise revolutionary advances in biology and medicine. However, several patent disputes in the USA and UK may have complicated who can use CRISPR. What does this mean for the future of gene editing?

Share

COinS